Detect 30 different types of canine cancer with a simple blood draw: Introducing liquid biopsy testing

Approved for one hour California Statutory CEU

**Click Here to RSVP**

NOTE: If you are experiencing any symptoms of COVID or have been in close contact with / were exposed to someone who tested positive for COVID within the past 10 days, we respectfully ask that you do not attend. If anyone is interested in attending via Zoom, let me know. We may attempt to offer this an option as well.

Lecture Summary / Objective: 

At its most fundamental level, cancer is caused by abnormalities in DNA. Advanced genomic sequencing technologies now allow for the identification of these abnormalities using a simple blood draw, opening the door to non-invasive cancer detection in dogs. This session will provide a basic overview of cancer biology and introduce the fundamentals of “liquid biopsy” for canine cancer detection using next-generation sequencing of cell-free DNA. A review of the peer-reviewed clinical validation study of this testing in over 1,000 dogs will be presented, along with case examples from real-world veterinary practices.

Speaker Bio:

Dr. Todd Cohen, is a board-certified, small animal internist who did his training at UC Davis and the University of Pennsylvania. He has over 17 years of clinical experience and recently made the move to industry, becoming the Director of Clinical Support at PetDx, following 13 years at VCA Animal Specialty and Emergency Clinic in West LA. Dr. Cohen’s current position involves providing clinical case consultations to veterinarians regarding liquid biopsy, as well as being intricately involved in ongoing clinical trials regarding this cutting-edge technology.